Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 0 | 2,048 | 1,181 | 957 | 0 |
| Cost of Goods | N/A | N/A | N/A | 444 | N/A |
| Gross Profit | N/A | 2,048 | 1,181 | 513 | N/A |
| Operating Expenses | 68,439 | 53,211 | 46,049 | 16,652 | 9,681 |
| Operating Income | -68,439 | -51,163 | -44,868 | -15,695 | -9,681 |
| Interest Expense | 508 | 8,016 | 6,754 | 4,804 | 872 |
| Other Income | -470 | 1,321 | 2,069 | 504 | 25 |
| Pre-tax Income | -69,417 | -57,858 | -49,553 | -19,995 | -10,528 |
| Net Income Continuous | -69,417 | -57,858 | -49,553 | -19,995 | -10,528 |
| Net Income Discontinuous | 35,925 | 3,937 | 4,594 | N/A | N/A |
| Net Income | $-33,492 | $-53,921 | $-44,959 | $-19,995 | $-10,528 |
| EPS Basic Total Ops | -1.05 | -1.89 | -2.70 | -2.23 | -1.19 |
| EPS Basic Continuous Ops | -2.18 | -2.03 | -2.97 | -2.23 | -1.19 |
| EPS Basic Discontinuous Ops | 1.13 | 0.14 | 0.27 | N/A | N/A |
| EPS Diluted Total Ops | -1.05 | -1.89 | -2.70 | -2.23 | -1.19 |
| EPS Diluted Continuous Ops | -2.18 | -2.03 | -2.97 | -2.23 | -1.19 |
| EPS Diluted Discontinuous Ops | 1.13 | 0.14 | 0.27 | N/A | N/A |
| EBITDA(a) | $-66,806 | $-49,235 | $-43,399 | $-14,180 | $-7,891 |